Form D · Private Equity Fund

OrbiMed Private Investments IX, LP

New York, NY · CIK 0001920984

Offering snapshot reported Apr 28, 2023 · SEC filing

Reported sold
$1.85B
Offering amount: $1.9B
Investors reported
141
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 29, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors0 → 141

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 28, 2023Amendment$1,849,550,000No comparison141SEC filing
Apr 28, 2022InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-443751
The total amount sold includes capital committed by the General Partner.

Source: Form D, filed Apr 28, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED PRIVATE INVESTMENTS IX, LP

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value
$2.19B
Beneficial owners
293
ADV minimum commitment
$1M

Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator HEDGESERV (CAYMAN) LTD. GEORGE TOWN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP NEW YORK, New York, United States
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 185

Filing source

Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-2258697554

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David P. Bonita Executive
Sven H. Borho Executive
Carl L. Gordon Executive
Geoffrey C. Hsu Executive
W. Carter Neild Executive
N/A Orbi Med Advisors Llc Executive
N/A Orbi Med Capital Gp Ix Llc Executive
Matthew S. Rizzo Executive
C. Scotland Stevens Executive
Peter A. Thompson Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
601 Lexington Avenue 54 Th Floor
New York, NY, 10022